| Topic, links to other documents |
WHO document |
Year |
| AIDS-associated opportunistic diseases |
Cotrimoxazole prophylaxis for malaria and bacterial infections in people with HIV |
2014 |
| AIDS-associated opportunistic diseases |
Guidelines on the treatment of skin and oral HIV-associated conditions in children and adults |
2014 |
| AIDS-associated opportunistic diseases |
Rapid advice: diagnosis, prevention and management of cryptococcal disease in HIV-infected adults, adolescents and children: December 2011 |
2011 |
| AIDS-associated opportunistic diseases |
Report of an informal working group on urogenital schistosomiasis and HIV transmission, Geneva, Switzerland, 1-2 October 2009 |
2010 |
| AIDS-associated opportunistic diseases |
Scoping consultation on chronic comorbidities in people living with HIV |
2014 |
| Anti-HIV agents |
2010 ART guidelines for adults and adolescents - evidence map |
2012 |
| Anti-HIV agents |
Access to antiretroviral drugs in low- and middle-income countries |
2014 |
| Anti-HIV agents |
Adoption of national recommendations related to use of antiretroviral therapy before and shortly following the launch of the 2013 WHO consolidated guidelines |
2014 |
| Anti-HIV agents |
Annual stakeholders and partners meeting: AIDS medicines and diagnostics service |
2012 |
| Anti-HIV agents |
Antiretroviral medicines in low- and middle-income countries: Forecasts of global and regional demand for 2013–2016 |
2014 |
| Anti-HIV agents |
Antiretroviral therapy for HIV infection in adults and adolescents. Recommendations for a public health approach (2010 revision) |
2010 |
| Anti-HIV agents |
Antiretroviral therapy initiation criteria in low resource settings – from ‘when to start’ to ‘when not to start’ |
2014 |
| Anti-HIV agents |
Community and service provider views to inform the 2013 WHO consolidated antiretroviral guidelines: key findings and lessons learnt |
2014 |
| Anti-HIV agents |
Consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection |
2013 |
| Anti-HIV agents |
Country experiences in implementing patient monitoring systems for HIV care and antiretroviral therapy in Ethiopia, Guyana and India : an overview of best practices and lessons learned |
2010 |
| Anti-HIV agents |
Early initiation of antiretroviral therapy in HIV-infected adults and adolescents: a systematic review |
2014 |
| Anti-HIV agents |
Global forecasts of antiretroviral demand 2012-2013: joint WHO/UNAIDS annual consultation with pharmaceutical companies |
2012 |
| Anti-HIV agents |
Global forecasts of antiretroviral demand 2012-2015: joint WHO/UNAIDS consultation with pharmaceutical companies and stakeholders |
2012 |
| Anti-HIV agents |
Health systems implications of the 2013 WHO consolidated antiretroviral guidelines and strategies for successful implementation |
2014 |
| Anti-HIV agents |
Improving antiretroviral therapy scale-up and effectiveness through service integration and decentralization |
2014 |
| Anti-HIV agents |
Increasing access to HIV treatment in middle-income countries |
2014 |
| Anti-HIV agents |
Interventions to improve adherence to antiretroviral therapy: a rapid systematic review |
2014 |
| Anti-HIV agents |
Joint WHO/UNAIDS annual consultation with pharmaceutical companies and stakeholders on forecasting global demand of antiretroviral drugs for 2013-2016 |
2014 |
| Anti-HIV agents |
March 2014 supplement to the 2013 consolidated guidelines on the use of antiretroviral drugs for treating and preventing HIV infection |
2014 |
| Anti-HIV agents |
Operational Guidance in the 2013 WHO consolidated antiretroviral guidelines |
2014 |
| Anti-HIV agents |
Optimal strategies for monitoring response to antiretroviral therapy in HIV-infected adults, adolescents, children and pregnant women: a systematic review |
2014 |
| Anti-HIV agents |
Patient evaluation and antiretroviral treatment for adults and adolescents : clinical protocol for the WHO European Region |
2012 |
| Anti-HIV agents |
Pharmacological equivalence and clinical interchangeability of lamivudine and emtricitabine: a review of current literature |
2012 |
| Anti-HIV agents |
Predicting treatment failure in adults and children on antiretroviral therapy: a systematic review of the performance characteristics of the 2010 WHO immunologic and clinical criteria for virologic failure |
2014 |
| Anti-HIV agents |
Scoping consultation on care packages for people living with HIV |
2014 |
| Anti-HIV agents |
Short-term priorities for antiretroviral drug optimization: meeting report |
2011 |
| Anti-HIV agents |
Simplification of antiretroviral therapy: a necessary step in the public health response to HIV/AIDS in resource-limited settings |
2014 |
| Anti-HIV agents |
Sources, quality and prices of active pharmaceutical ingredients of antiretroviral drugs |
2012 |
| Anti-HIV agents |
The impact and cost of the 2013 WHO recommendations on eligibility for antiretroviral therapy |
2014 |
| Anti-HIV agents |
The monitoring of adults and children on antiretroviral therapy in the 2013 WHO consolidated ARV guidelines |
2014 |
| Anti-HIV agents |
The strategic use of antiretrovirals to help end the HIV epidemic |
2012 |
| Anti-HIV agents |
Transaction prices for antiretroviral medicines from 2009 to 2012 |
2012 |
| Anti-HIV agents |
Transition to new HIV treatment regimens – procurement and supply chain management issues |
2014 |
| Anti-HIV agents |
WHO consultation: the strategic use of antiretrovirals for treatment and prevention of HIV infection: 2nd Expert Panel meeting: executive summary: 4 May 2012, Geneva |
2012 |
| Anti-HIV agents |
WHO informal consultation on medium- and long-term priorities for ARV drug optimization |
2012 |
| Anti-HIV agents: adverse events, complications |
Scoping consultation on priority areas and required work on ARV toxicity |
2015 |
| Anti-HIV agents: adverse events, complications |
Surveillance of antiretroviral drug toxicity within antiretroviral treatment programmes |
2013 |
| Anti-HIV agents: adverse events, complications |
WHO Technical review meeting on country experiences in ARV toxicity surveillance - Sharing preliminary results and lessons learnt, identifying solutions |
2013 |
| Anti-HIV agents: drug resistance |
Assessment of WHO HIV drug resistance early warning indicators |
2012 |
| Anti-HIV agents: drug resistance |
Report on WHO ResNet Annual Meeting |
2012 |
| Anti-HIV agents: drug resistance |
Surveillance of HIV drug resistance in adults initiating antiretroviral therapy |
2014 |
| Anti-HIV agents: drug resistance |
Surveillance of HIV drug resistance in adults receiving ART |
2014 |
| Anti-HIV agents: drug resistance |
WHO global strategy for the surveillance and monitoring of HIV drug resistance 2012 |
2012 |
| Anti-HIV agents: drug resistance |
WHO HIV drug resistance report 2012 |
2012 |
| Anti-HIV agents: drug resistance |
WHO manual for HIV drug resistance testing using dried blood spot specimens |
2012 |
| Anti-HIV agents: microbicides |
Preparing for access to PRO 2000 microbicide: report of a meeting, 27-28 May 2009, London, United Kingdom |
2010 |
| Anti-HIV agents: microbicides |
Regulatory issues in microbicide development |
2010 |
| Anti-HIV agents: microbicides |
Stakeholder consultation on priority implementation research to inform development of WHO normative guidance on topical pre-exposure prophylaxis |
2015 |
| Anti-HIV agents: post-exposure prophylaxis |
Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children |
2014 |
| Cervical cancer |
Comprehensive cervical cancer control: a guide to essential practice - Second edition |
2014 |
| Cervical cancer |
Comprehensive cervical cancer prevention and control - a healthier future for girls and women. WHO guidance note |
2013 |
| Cervical cancer |
Strengthening cervical cancer prevention and control: report of the GAVI-UNFPA-WHO meeting |
2010 |
| Cervical cancer |
WHO guidelines for screening and treatment of precancerous lesions for cervical cancer prevention |
2013 |
| Cervical cancer: human papillomavirus |
Human papillomavirus laboratory manual |
2010 |
| Cervical cancer: screening |
Monitoring national cervical cancer prevention and control programmes |
2013 |
| Cervical cancer: screening |
Prevention of cervical cancer through screening using visual inspection with acetic acid (VIA) and treatment with cryotherapy |
2012 |
| Cervical cancer: treatment |
Cryosurgical equipment for the treatment of precancerous cervical lesions and prevention of cervical cancer |
2012 |
| Cervical cancer: treatment |
Treatment of cervical intraepithelial neoplasia 2–3 and adenocarcinoma in situ: cryotherapy, large loop excision of the transformation zone, and cold knife conization |
2014 |
| Cervical cancer: treatment |
Use of cryotherapy for cervical intraepithelial neoplasia: Evidence base |
2012 |
| Cervical cancer: treatment |
WHO guidelines: use of cryotherapy for cervical intraepithelial neoplasia |
2011 |
| Cervical cancer: vaccine |
Options for linking health interventions for adolescents with HPV vaccination |
2014 |
| Cervical cancer: vaccine |
Report of the meeting on HPV vaccine coverage and impact monitoring, 16-17 November 2009, Geneva, Switzerland |
2010 |
| Cervical cancer: vaccine |
The immunological basis for immunization series: module 19: human papillomavirus infection |
2011 |
| Chlamydia infections |
WHO guidelines for the treatment of Chlamydia trachomatis |
2016 |
| Congenital syphilis |
Global Estimates of Syphilis in Pregnancy and Associated Adverse Outcomes: Analysis of Multinational Antenatal Surveillance Data |
2013 |
| Congenital syphilis |
Investment case for eliminating mother-to-child transmission of syphilis |
2012 |
| Congenital syphilis |
Methods for surveillance and monitoring of congenital syphilis elimination within existing systems |
2011 |
| Ethics, jurisprudence: HIV/AIDS |
HIV/AIDS - stand up for human rights |
2010 |
| Ethics, jurisprudence: HIV/AIDS |
HIV prevention, treatment and care in prisons and other closed settings: A comprehensive package of interventions |
2013 |
| Gonorrhea |
Emergence of multi-drug resistant Neisseria gonorrhoeae : threat of global rise in untreatable sexually transmitted infections |
2011 |
| Gonorrhea |
Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae |
2012 |
| Gonorrhea |
WHO guidelines for the treatment of Neisseria gonorrhoeae |
2016 |
| Herpes |
Herpes simplex virus |
2016 |
| HIV prevention |
Conclusions: WHO and U.S. NIH working group meeting on treatment for HIV prevention among MSM: What additional evidence is required? |
2011 |
| HIV prevention |
Guidance on couples HIV testing and counselling including antiretroviral therapy for treatment and prevention in serodiscordant couples: recommendations for a public health approach |
2012 |
| HIV prevention |
Guidance on oral pre-exposure prophylaxis (PrEP) for serodiscordant couples, men and transgender women who have sex with men at high risk of HIV |
2012 |
| HIV prevention |
Guidelines: prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender populations: recommendations for a public health approach 2011 |
2011 |
| HIV prevention |
HIV prevention in generalized epidemics: optimal interventions for Global Fund applications: recommendations for a public health approach - 2011 |
2011 |
| HIV prevention |
How to integrate water, sanitation and hygiene into HIV programmes |
2010 |
| HIV prevention |
Technical update on pre-exposure prophylaxis (PrEP) |
2015 |
| HIV prevention |
WHO consultation on PrEP adherence |
2014 |
| HIV prevention: male circumcision |
Framework for clinical evaluation of devices for male circumcision |
2012 |
| HIV prevention: male circumcision |
Guideline on the use of devices for adult male circumcision for HIV prevention |
2013 |
| HIV prevention: male circumcision |
Joint strategic action framework to accelerate the scale-up of voluntary medical male circumcision for HIV prevention in eastern and southern Africa : 2012-2016 |
2011 |
| HIV prevention: male circumcision |
Manual for early infant male circumcision under local anaesthesia |
2010 |
| HIV prevention: male circumcision |
Progress in male circumcision scale-up: country implementation and research update |
2010 |
| HIV prevention: male circumcision |
Progress in scale-up of male circumcision for HIV prevention in Eastern and Southern Africa: focus on service delivery - 2011 revised |
2011 |
| HIV prevention: male circumcision |
Use of devices for adult male circumcision for HIV prevention in East and Southern Africa |
2014 |
| HIV prevention: male circumcision |
Use of devices for adult male circumcision in public health HIV prevention programmes : conclusions of the WHO Technical Advisory Group on Innovations in Male Circumcision |
2012 |
| HIV prevention: male circumcision |
WHO Progress Brief - Voluntary medical male circumcision for HIV prevention in priority countries of East and Southern Africa |
2014 |
| HIV prevention: male circumcision |
WHO technical advisory group on innovations in male circumcision |
2015 |
| HIV testing and diagnosis |
A handbook for improving HIV testing and counselling services - field-test version |
2010 |
| HIV testing and diagnosis |
A short technical update on self-testing for HIV |
2014 |
| HIV testing and diagnosis |
Consolidated guidelines on HIV testing services |
2015 |
| HIV testing and diagnosis |
Guide for monitoring and evaluating national HIV testing and counselling (HTC) programmes: field-test version |
2011 |
| HIV testing and diagnosis |
HIV self-testing among health workers: a review of the literature and discussion of current practices, issues and options for increasing access to HIV testing in Sub-Saharan Africa |
2011 |
| HIV testing and diagnosis |
HIV testing in young children : technical briefing paper |
2011 |
| HIV testing and diagnosis |
Improving HIV testing and counselling services : technical briefing paper |
2011 |
| HIV testing and diagnosis |
Planning, implementing and monitoring home-based HIV testing and counselling. A practical handbook for Sub-Saharan Africa |
2012 |
| HIV testing and diagnosis |
Policy Statement on HIV Testing and Counselling for Refugees and other persons of concern to UNHCR |
2014 |
| HIV testing and diagnosis |
Provider-initiated HIV testing and counselling: one-day training programme, field test version April 2011 |
2011 |
| HIV testing and diagnosis |
Realizing the potential of HIV self-testing |
2014 |
| HIV testing and diagnosis |
Scaling up HIV testing and counselling in the WHO European Region as an essential component of efforts to achieve universal access to HIV prevention, treatment, care and support : policy framework |
2010 |
| HIV testing and diagnosis |
Scaling up HIV testing and counselling as an important component of efforts to achieve universal access to HIV prevention, treatment, care and support in the WHO European Region: WHO technical consultation : Ljubljana, Slovenia 8-10 June 2009 |
2010 |
| HIV testing and diagnosis |
Service delivery approaches to HIV testing and counselling (HTC): A strategic policy framework |
2012 |
| HIV testing and diagnosis |
Specifications and quantities for efficient procurement of essential equipment and laboratory commodities for HIV |
2014 |
| HIV testing and diagnosis |
Technical and operational considerations for implementing HIV viral load testing |
2014 |
| HIV testing and diagnosis |
The availability and use of diagnostics for HIV: a 2012/2013 WHO survey of low- and middle-income countries |
2014 |
| HIV testing and diagnosis |
WHO recommendations to assure HIV testing quality |
2015 |
| HIV testing and diagnosis |
WHO reminds national programmes to retest all newly diagnosed people with HIV |
2014 |
| HIV/AIDS |
A new health sector agenda for HIV/AIDS: global health sector strategy on HIV/AIDS, 2011-2015 |
2011 |
| HIV/AIDS |
Adapting WHO normative HIV guidelines for national programmes: essential principles and processes |
2011 |
| HIV/AIDS |
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations |
2014 |
| HIV/AIDS |
Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations: 2016 update |
2016 |
| HIV/AIDS |
Consolidated strategic information guidelines for HIV in the health sector |
2015 |
| HIV/AIDS |
Global health sector strategy on HIV/AIDS 2011-2015 |
2011 |
| HIV/AIDS |
Global update on the health sector response to HIV, 2014 |
2014 |
| HIV/AIDS |
HIV/AIDS |
2016 |
| HIV/AIDS |
HIV programme: Achieving our goals |
2014 |
| HIV/AIDS |
HIV operational plan 2012-2013: WHO's support to implement the Global health sector strategy on HIV/AIDS |
2012 |
| HIV/AIDS |
HIV, universal health coverage and the post-2015 development agenda |
2014 |
| HIV/AIDS |
Planning guide for the health sector response to HIV/AIDS |
2011 |
| HIV/AIDS |
Policy brief: Consolidated guidelines on HIV prevention, diagnosis, treatment and care for key populations |
2014 |
| HIV/AIDS |
Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people |
2011 |
| HIV/AIDS |
Prevention and treatment of HIV and other sexually transmitted infections for sex workers in low- and middle-income countries |
2012 |
| HIV/AIDS |
Priority interventions : HIV/ AIDS prevention, treatment and care in the health sector |
2010 |
| HIV/AIDS |
Retention in HIV programmes: defining the challenges and identifying solutions: meeting report, 13-15 September 2011 |
2012 |
| HIV/AIDS |
Tool to set and monitor targets for HIV prevention, diagnosis, treatment and care for key populations |
2015 |
| HIV/AIDS |
Towards universal access: scaling up priority HIV/AIDS interventions in the health sector: progress report 2010 |
2010 |
| HIV/AIDS |
Transgender people and HIV |
2015 |
| HIV/AIDS |
WHO expert meeting on short-term HIV diagnosis, treatment initiation and monitoring technologies and approaches, Geneva, Switzerland 3-14 October 2011: meeting report |
2012 |
| HIV/AIDS and breastfeeding/infant feeding |
Guidelines on HIV and infant feeding 2010 |
2010 |
| HIV/AIDS and breastfeeding/infant feeding |
Kesho Bora Study: preventing mother-to-child transmission of HIV during breastfeeding: policy brief |
2011 |
| HIV/AIDS and hepatitis |
HIV and HCV: distinct infections with important overlapping challenges |
2014 |
| HIV/AIDS and hepatitis |
Management of hepatitis B and HIV coinfection: clinical protocol for the WHO European Region |
2012 |
| HIV/AIDS and syphilis |
Elimination of mother-to-child transmission (EMTCT) of HIV and syphilis |
2014 |
| HIV/AIDS and tuberculosis |
A guide to monitoring and evaluation for collaborative TB/HIV activities |
2015 |
| HIV/AIDS and tuberculosis |
Caring for newborns and children in the community, adaptation for high HIV or TB settings |
2014 |
| HIV/AIDS and tuberculosis |
Guidelines for intensified tuberculosis case finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings |
2011 |
| HIV/AIDS and tuberculosis |
Joint WHO/ILO policy guidelines on improving health worker access to prevention, treatment and care services for HIV and TB |
2010 |
| HIV/AIDS and tuberculosis |
Priority research questions for tuberculosis/human immunodeficiency virus (TB/HIV) in HIV-prevalent and resource-limited settings |
2010 |
| HIV/AIDS and tuberculosis |
Programmatic update: antiretroviral treatment as prevention (TASP) of HIV and TB: executive summary |
2012 |
| HIV/AIDS and tuberculosis |
Three interlinked patient monitoring systems for HIV care/ART, MCH/PMTCT (including malaria prevention during pregnancy), and TB/HIV: standardized minimum data set and illustrative tools |
2013 |
| HIV/AIDS and tuberculosis |
WHO policy on collaborative TB/HIV activities : guidelines for national programmes and other stakeholders |
2012 |
| HIV/AIDS and tuberculosis |
Working together with businesses: guidance on TB and TB/HIV prevention, diagnosis, treatment and care in the workplace |
2012 |
| HIV/AIDS in pregnancy and newborn |
Annual meeting of the Interagency Task Team on Prevention and Treatment of HIV Infection in Pregnant Women, Mothers and their Children |
2011 |
| HIV/AIDS in pregnancy and newborn |
Antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Recommendations for a public health approach. 2010 Revision |
2010 |
| HIV/AIDS in pregnancy and newborn |
Antiretroviral treatment for pregnant and breastfeeding women – the shifting paradigm |
2014 |
| HIV/AIDS in pregnancy and newborn |
Global monitoring framework and strategy for the Global Plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive |
2012 |
| HIV/AIDS in pregnancy and newborn |
Guideline: vitamin A supplementation in pregnancy for reducing the risk of mother-to-child transmission of HIV |
2011 |
| HIV/AIDS in pregnancy and newborn |
Male involvement in the prevention of mother-to-child transmission of HIV |
2012 |
| HIV/AIDS in pregnancy and newborn |
Measuring the impact of national PMTCT programmes: Towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive |
2012 |
| HIV/AIDS in pregnancy and newborn |
Meeting report: 2011 annual meeting of the interagency task team on prevention and treatment of HIV infection in pregnant women, mothers and their children |
2011 |
| HIV/AIDS in pregnancy and newborn |
PMTCT strategic vision 2010-2015 : preventing mother-to-child transmission of HIV to reach the UNGASS and Millennium Development Goals : moving towards the elimination of paediatric HIV, December 2009 |
2010 |
| HIV/AIDS in pregnancy and newborn |
Programmatic update: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants: executive summary |
2012 |
| HIV/AIDS in pregnancy and newborn |
Rapid advice: use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants. Version 2 |
2010 |
| HIV/AIDS in pregnancy and newborn |
Report of the meeting of the paediatric working group developing an optimized list of paediatric ARV formulations |
2012 |
| HIV/AIDS in pregnancy and newborn |
Safety of efavirenz in the first trimester of pregnancy: an updated systematic review and meta-analysis |
2014 |
| HIV/AIDS in pregnancy and newborn |
Towards the elimination of mother-to-child transmission of HIV in low-prevalence and concentrated epidemic settings in Eastern Europe and Central Asia |
2011 |
| HIV/AIDS in pregnancy and newborn |
Towards the elimination of mother-to-child transmission of HIV: report of a WHO technical consultation, 9-11 November 2010, Geneva, Switzerland |
2011 |
| HIV/AIDS in pregnancy and newborn |
Use of antiretroviral drugs for treating pregnant women and preventing HIV infection in infants |
2012 |
| HIV/AIDS in pregnancy and newborn |
Use of efavirenz during pregnancy: A public health perspective |
2012 |
| HIV/AIDS: epidemiology |
A hidden epidemic: HIV, men who have sex with men and transgender people in Eastern Europe and Central Asia: regional consultation, Kyiv, Ukraine 22-24 November 2010. Meeting report |
2011 |
| HIV/AIDS: epidemiology |
Global AIDS response progress reporting 2013 |
2013 |
| HIV/AIDS: epidemiology |
Global HIV/AIDS response: epidemic update and health sector progress towards universal access: progress report 2011 |
2011 |
| HIV/AIDS: epidemiology |
Guidelines for HIV mortality measurement |
2014 |
| HIV/AIDS: epidemiology |
Guidelines on estimating the size of populations most at risk to HIV |
2010 |
| HIV/AIDS: epidemiology |
Guidelines on surveillance among populations most at risk for HIV |
2011 |
| HIV/AIDS: epidemiology |
HIV/AIDS surveillance in Europe 2009 : surveillance report |
2010 |
| HIV/AIDS: epidemiology |
HIV/AIDS surveillance in Europe 2010: surveillance report |
2011 |
| HIV/AIDS: epidemiology |
When and how to use assays for recent infection to estimate HIV incidence at a population level |
2011 |
| HIV/AIDS: epidemiology |
WHO/UNAIDS annual meeting of the technical Working Group on HIV Incidence Assays |
2015 |
| HIV/AIDS: sex workers |
Implementing comprehensive HIV/STI programmes with sex workers: practical approaches from collaborative interventions |
2013 |
| HIV/AIDS: sexual and reproductive health, family planning |
Hormonal contraception and HIV: technical statement |
2012 |
| HIV/AIDS: sexual and reproductive health, family planning |
Hormonal contraceptive methods for women at high risk of HIV and living with HIV |
2014 |
| HIV/AIDS: sexual and reproductive health, family planning |
Making the case for interventions linking sexual and reproductive health and HIV in proposals to the Global Fund to Fight AIDS, Tuberculosis and Malaria |
2010 |
| HIV/AIDS: sexual and reproductive health, family planning |
Programmatic and research considerations for hormonal contraception for women at risk of HIV and women living with HIV |
2012 |
| HIV/AIDS: sexual and reproductive health, family planning |
Reproductive choices and family planning for people living with HIV - Counselling tool |
2012 |
| HIV/AIDS: sexual and reproductive health, family planning |
Review of priorities in research: Hormonal contraception and IUDs and HIV infection |
2010 |
| HIV/AIDS: substance abuse |
Technical guide for countries to set targets for universal access to HIV prevention, treatment and care for injecting drug users, 2012 revision |
2013 |
| Sexually transmitted diseases |
Expert consultation and review of the latest evidence to update guidelines for the management of sexually transmitted infections. Meeting report. |
2011 |
| Sexually transmitted diseases |
Global health sector strategy on Sexually Transmitted Infections, 2016-2021 |
2016 |
| Sexually transmitted diseases |
Sexually Transmitted Infections (STIs) |
2013 |
| Sexually transmitted diseases |
Sexually transmitted infections (STIs). Fact sheet |
2016 |
| Sexually transmitted diseases: epidemiology |
A tool for strengthening STI surveillance at the country level |
2015 |
| Sexually transmitted diseases: epidemiology |
Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting |
2015 |
| Sexually transmitted diseases: epidemiology |
Global incidence and prevalence of selected curable sexually transmitted infections – 2008 |
2012 |
| Sexually transmitted diseases: epidemiology |
Prevalence and incidence of selected sexually transmitted infections, Chlamydia trachomatis, Neisseria gonorrhoeae, syphilis and trichomonas vaginalis: methods and results used by WHO to generate 2005 estimates |
2011 |
| Sexually transmitted diseases: epidemiology |
Report on global sexually transmitted infection surveillance 2013 |
2014 |
| Sexually transmitted diseases: epidemiology |
Strategies and laboratory methods for strengthening surveillance of sexually transmitted infection 2012 |
2012 |
| Sexually transmitted diseases: prevention |
Progress report of the implementation of the global strategy for prevention and control of sexually transmitted infections: 2006–2015 |
2015 |
| Sexually transmitted diseases: prevention |
Scaling up sexually transmitted infection prevention and control in the WHO European Region : technical consultation, Ljubljana, Slovenia, 2-4 August 2010 |
2011 |
| Sexually transmitted diseases: screening, diagnosis |
Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus |
2013 |
| Syphilis |
WHO guidelines for the treatment of Treponema pallidum (syphilis) |
2016 |